A KAUST team led by Xin Gao developed an AI model for COVID-19 detection from CT scans, addressing limitations of existing methods. The model incorporates a novel embedding strategy, a CT scan simulator, and a 2.5D deep-learning algorithm. Tested at King Faisal Specialist Hospital, the model demonstrated high accuracy in detecting COVID-19 cases. Why it matters: This research provides a valuable tool for rapid and accurate COVID-19 diagnosis in the region, especially in early-stage infections, improving healthcare outcomes.
MBZUAI is developing AI algorithms to intelligently process data from wearables and home sensors for remote patient monitoring. The algorithms aim to analyze multiple strands of health data to provide a more comprehensive view of a patient's health, distinguishing between genuine emergencies and benign situations. MBZUAI's provost, Professor Fakhri Karray, believes this approach could handle 20-25% of diagnoses virtually, reducing the burden on healthcare systems. Why it matters: This research could significantly improve healthcare efficiency and accessibility in the UAE and beyond by enabling more effective remote patient monitoring and reducing unnecessary hospital visits.
MBZUAI researchers led by Dr. Mohammad Yaqub are developing AI algorithms for real-time medical diagnoses, including tools for multiple sclerosis and congenital heart disease. The team developed ScanNav, an AI fetal anomaly assessment system licensed by GE Healthcare for Voluson SWIFT ultrasound machines. ScanNav assists doctors during anomaly scans after 20 weeks of gestation to check for conditions like heart issues and spina bifida. Why it matters: This research has the potential to significantly improve the speed and accuracy of medical diagnoses in the UAE and beyond, addressing critical gaps in healthcare.
MBZUAI's Dr. Mohammad Yaqub is developing AI algorithms to power point-of-care ultrasound (PoCUS) on mobile devices, expanding on his prior work on an AI-based fetal anomaly system used in GE Healthcare's ultrasound. These algorithms aim to make smaller, affordable PoCUS devices accessible in remote areas for faster diagnoses. The handheld devices, costing around $5000 USD, can connect to mobile devices and provide intelligence to interpret images, addressing the shortage of specialists in remote locations. Why it matters: This initiative democratizes access to critical diagnostic tools, potentially saving lives by enabling early detection of life-threatening conditions in underserved communities.
MBZUAI researchers are developing AI applications for malaria prevention in Indonesia using sensory data fusion and digital twins. Another MBZUAI team is using machine learning and computer vision to detect cardiovascular disease from CT scans in collaboration with the University of Oxford. AI-powered remote patient monitoring is also being explored for proactive interventions and chronic disease management. Why it matters: These projects demonstrate the potential of AI to address healthcare challenges in underserved communities and improve disease prevention and management in the region.